Elekta
| Elekta
|
|
|---|---|
 |
|
| legal form | Aktiebolag (AB) |
| ISIN | SE0000163628 |
| founding | 1972 |
| Seat |
Stockholm , Sweden
|
| management | Richard Hausmann ( CEO ) , Laurent Leksell (Chairman) |
| Number of employees | 3600 (as of December 2015) |
| sales | 11.22 billion SEK (approx. 1.17 billion euros) |
| Branch | Medical technology manufacturer |
| Website | www.elekta.com |
| As of December 31, 2015 | |
Elekta is an international company in the medical technology sector, whose products mainly come from the field of radiation therapy . The company's headquarters are in Stockholm . The company's shares have been traded on the Nordic Exchange , the Stockholm Stock Exchange, under the symbol EKTAb since 1994 . The company generated sales of SEK 11.22 billion in the 2015/2016 financial year , corresponding to around EUR 1.17 billion. As of the 2015/2016 financial year, the company had 3,600 employees worldwide. Outside Sweden, the company has offices in Finland, the Netherlands, Great Britain, the United States, China and Germany, among others. There are more than twenty subsidiaries in total.
history
The company was founded in 1972 by the Swedish neurosurgeon Lars Leksell . Leksell was a professor at the Karolinska Institute and is considered to be the inventor of radiation therapy with the gamma knife . Together with the Swedish physicist Börje Larsson , he established the beginning of the field of radiosurgery . So far, around half a million head and neck cancer patients have been treated with the Gamma Knife.
In 1997 Elekta took over the radiotherapy part of Philips Medizinsysteme and has since then had other companies such as B. the Finnish MEG manufacturer Neuromag .
In 2005 Elekta took over the company medical intelligence from Schwabmünchen . In the spring of 2008, Elekta signed a letter of intent in which it announced its intention to take over the US medical software company CMS ( Computerized Medical Systems ). On March 1, 2008 the due diligence was ended and the developer of radiation planning software was taken over.
In 2011, with effect from September 15, 2011, Nucletron BV (Netherlands), a manufacturer of devices and planning software for brachytherapy, was taken over at a price of € 365 million.
Products
- Leksell gamma knife
- Linear accelerator
- Auxiliary devices for immobilizing the patient
- Treatment planning software
- Magnetoencephalograph
See also
Web links
- Official Homepage (English)
- The history of the Gamma Knife (PDF; 14 kB; English)
- Homepage medical intelligence (English)
Individual evidence
- ↑ a b Annual report for the 2015/2016 financial year ( memento of the original from April 14, 2017 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. (PDF; 3.1 MB) elekta.com (English); accessed April 27, 2017
- ↑ elekta.com ( Memento of the original from March 2, 2008 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice.
